You are here: Industry Insights > CESS

News List

Nanoform and Boehringer Ingelheim execute master services agreement prnasia
August 03, 2021
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform's award-winning CESS® technology can deliver to its drug development p
Additional Positive Interim Results from Nanoform's Clinical Study prnasia
February 24, 2021
Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study.
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule prnasia
October 22, 2020
Nanoform Finland Plc, an innovative nanoparticle medicine enabling company will, in the fourth quarter of 2020, start the first ever human trial of a drug candidate nanoformed using Nanoform's proprietary CESS® technology.
Nanoform Awarded GMP Certification contractpharma
May 07, 2020
To manufacture investigational drug developed using its CESS nanoparticle engineering platform for use in clinical trials.
Nanoform, Orion Enter Next-gen Drug Development Pact contractpharma
March 10, 2020
Nanoform, a nanoparticle medicine enabling company, and Orion Corp., a pharmaceutical company, have entered a collaboration to apply Nanoform's CESS technology to new chemical entities to improve the bioavailability ...